Forecast & Rating2 analysts currently cover Nautilus Biotechnology, of which 2 give a positive rating. The average price target is $4.00, about 311.4% upside from the current price of $0.97. Coverage is limited, so the data is for reference only. Data as of Jul 28, 2026; this does not constitute investment advice.
Jul 28, 2026Price forecast
$4.00311.35%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 30, 2026
Forecast met25.0%
Stock price$0.97
Avg. target$4.0
High target$4
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.